Expert Review on the Use of Methylphenidate in Children and Adult With Epilepsy and Attention Deficit Hyperactivity Disorder
Revista de Neurología · 29.10.2026 · 81 (10)
DOI: 10.31083/rn52291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Revista de Neurología, online erschienen am 29.10.2026. Verfasst von Víctor Soto Insuga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Neurología, Hospital Niño Jesús, 28009 Madrid, Spain. Hauptthemen laut MEDLINE: Methylphenidate, Attention Deficit Disorder with Hyperactivity, Epilepsy, Central Nervous System Stimulants. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Attention deficit hyperactivity disorder (ADHD) is a comorbidity affecting 12%–29% of individuals with epilepsy, significantly impacting learning, psychosocial development, behaviour, and quality of life. Moreover, ADHD and epilepsy share a bidirectional relationship. Although methylphenidate has been proven effective in alleviating ADHD symptoms, its use remains limited in individuals with epilepsy due to outdated concerns—dating back over 20 years—that psychostimulants could increase seizure frequency. This manuscript presents a narrative review of the scientific literature published between January 2000 and May 2026 regarding the use of methylphenidate in patients with epilepsy and ADHD. Based on the available evidence, a panel of paediatric neurologists from five Spanish tertiary hospitals with expertise in epilepsy and neurodevelopmental disorders reached an expert consensus and developed a series of practical recommendations for the assessment and management of these patients. This expert group issued several recommendations, including the proactive screening of ADHD symptoms in all children and adults with epilepsy from the onset of the condition. Current evidence has not consistently demonstrated an increased seizure risk associated with methylphenidate in patients with epilepsy, although available data remain limited for some epilepsy subgroups. Furthermore, undertreatment of ADHD is associated with poorer patient outcomes. Methylphenidate may be considered in children and adults with epilepsy when clinically indicated, following optimization of epilepsy management, associated comorbidities, and behavioural and psychosocial interventions. Treatment decisions should be individualized, particularly in patients with active epilepsy, drug-resistant epilepsy, recent seizure worsening, or developmental and epileptic encephalopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Neurología, Hospital Niño Jesús, 28009 Madrid, Spain.
- Área de Neurología Pediátrica y Neurofisiología. Hospital Sant Joan de Déu. Institut de Recerca Sant Joan de Déu. EpiCARE Coordinator Center, 08950 Barcelona, Spain.
- Servicio de Pediatría, Hospital Miguel Servet, 50009 Zaragoza, Spain.
- Unidad de Neuropediatría, Servicio de Pediatría, Hospital Universitario de Navarra, 31008 Pamplona, Spain.
- Unidad de Neurología Pediátrica, AGC de Pediatría, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Zitieren
APA
Soto Insuga, V., Russi, M. E., González Alguacil, E., López Pisón, J., Aguilera Albesa, S., Málaga Dieguez, I., & Fons, C. (2026). Expert Review on the Use of Methylphenidate in Children and Adult With Epilepsy and Attention Deficit Hyperactivity Disorder. Revista de Neurología, 81(10). https://doi.org/10.31083/rn52291
Vancouver
Soto Insuga V, Russi ME, González Alguacil E, López Pisón J, Aguilera Albesa S, Málaga Dieguez I, et al. Expert Review on the Use of Methylphenidate in Children and Adult With Epilepsy and Attention Deficit Hyperactivity Disorder. Revista de Neurología. 2026;81(10). doi:10.31083/rn52291
BibTeX
@article{SotoInsuga2026,
author = {Soto Insuga, Víctor and Russi, María Eugenia and González Alguacil, Elena and López Pisón, Javier and Aguilera Albesa, Sergio and Málaga Dieguez, Ignacio and Fons, Carmen},
title = {Expert Review on the Use of Methylphenidate in Children and Adult With Epilepsy and Attention Deficit Hyperactivity Disorder},
journal = {Revista de Neurología},
year = {2026},
volume = {81},
number = {10},
doi = {10.31083/rn52291}
}
EUVIMED